FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386957463> ?p ?o ?g. }

• W4386957463 abstract "Background. Human papillomavirus (HPV) has been established to be the etiological factor of cervical cancer (CC). HPV infection and CC progression involve the direct participation of the E6 oncoprotein. Aim. An analysis of the E6 oncoprotein levels in tissues of the tumor and its perifocal area in HPV-associated cervical squamous cell cancer as an objective indicator of the effect of treatment depending on preoperative chemotherapy. Material and methods. The study included clinical and lab- oratory data of 237 patients with high-risk HPV infection of the cervix. The patients were divided into 4 groups: two main groups (CC T2а2-2bN0-1M0) and two control groups. Patients in the main group 1 (n=84) received standard neoadjuvant chemotherapy (NACT), in the main group 2 (n=93) - modified NACT with prior plasmapheresis session and a parallel course of nonspecific immunotherapy with Allokin-alpha. Control group 1 (n=40) included patients with CC T1b2-2a1N0-1M0, surgical treatment; control group 2 (n=20) - HPV-positive patients without CC. Levels of E6 were measured in samples of the cervical tumor and perifocal tissues. Results. The lowest levels of the E6 oncoprotein were registered in the group of HPV-positive patients without CC. After modified NACT, E6 levels in tumor tissues remained 4.6 times higher than in intact tissues, and even so, these patients demonstrated minimal E6 levels compared to other CC patients. E6 in tumor tissues was significantly lower than in main group 1 (by 3.3 times) and 8 times lower than in control group 1. E6 levels in the perifocal tissues of patients in main group 2 were 1.9 times lower than in the corresponding tissues of patients in main group 1 and 2.2 times lower than in control group 1. Conclusions. Inclusion of plasmapheresis and inducers of endogenous interferonogenesis into neoadjuvant treatment for cervical cancer can be considered pathogenetically justified, since it affects the key unit of cervical carcinogenesis." @default.
• W4386957463 created "2023-09-23" @default.
• W4386957463 creator A5012544880 @default.
• W4386957463 creator A5030759299 @default.
• W4386957463 creator A5033349267 @default.
• W4386957463 creator A5079181636 @default.
• W4386957463 creator A5092922220 @default.
• W4386957463 date "2023-09-22" @default.
• W4386957463 modified "2023-09-29" @default.
• W4386957463 title "EFFECT OF MODIFIED NEOADJUVANT CHEMOTHERAPY ON LEVELS OF E6 ONCOPROTEIN IN HPV-INFECTED CERVICAL TUMOR TISSUE" @default.
• W4386957463 cites W1970779614 @default.
• W4386957463 cites W2087955499 @default.
• W4386957463 cites W2162862905 @default.
• W4386957463 cites W2538848574 @default.
• W4386957463 cites W2797226630 @default.
• W4386957463 cites W2889646458 @default.
• W4386957463 cites W2895926103 @default.
• W4386957463 cites W2949397489 @default.
• W4386957463 cites W2951105094 @default.
• W4386957463 cites W3010914431 @default.
• W4386957463 cites W3012816036 @default.
• W4386957463 cites W3135654454 @default.
• W4386957463 cites W3142780458 @default.
• W4386957463 doi "https://doi.org/10.37539/230629.2023.23.47.025" @default.
• W4386957463 hasPublicationYear "2023" @default.
• W4386957463 type Work @default.
• W4386957463 citedByCount "0" @default.
• W4386957463 crossrefType "proceedings-article" @default.
• W4386957463 hasAuthorship W4386957463A5012544880 @default.
• W4386957463 hasAuthorship W4386957463A5030759299 @default.
• W4386957463 hasAuthorship W4386957463A5033349267 @default.
• W4386957463 hasAuthorship W4386957463A5079181636 @default.
• W4386957463 hasAuthorship W4386957463A5092922220 @default.
• W4386957463 hasConcept C121608353 @default.
• W4386957463 hasConcept C126322002 @default.
• W4386957463 hasConcept C137627325 @default.
• W4386957463 hasConcept C143998085 @default.
• W4386957463 hasConcept C2776694085 @default.
• W4386957463 hasConcept C2777701055 @default.
• W4386957463 hasConcept C2777740455 @default.
• W4386957463 hasConcept C2778220009 @default.
• W4386957463 hasConcept C2778580637 @default.
• W4386957463 hasConcept C2994532551 @default.
• W4386957463 hasConcept C71924100 @default.
• W4386957463 hasConcept C90924648 @default.
• W4386957463 hasConceptScore W4386957463C121608353 @default.
• W4386957463 hasConceptScore W4386957463C126322002 @default.
• W4386957463 hasConceptScore W4386957463C137627325 @default.
• W4386957463 hasConceptScore W4386957463C143998085 @default.
• W4386957463 hasConceptScore W4386957463C2776694085 @default.
• W4386957463 hasConceptScore W4386957463C2777701055 @default.
• W4386957463 hasConceptScore W4386957463C2777740455 @default.
• W4386957463 hasConceptScore W4386957463C2778220009 @default.
• W4386957463 hasConceptScore W4386957463C2778580637 @default.
• W4386957463 hasConceptScore W4386957463C2994532551 @default.
• W4386957463 hasConceptScore W4386957463C71924100 @default.
• W4386957463 hasConceptScore W4386957463C90924648 @default.
• W4386957463 hasLocation W43869574631 @default.
• W4386957463 hasOpenAccess W4386957463 @default.
• W4386957463 hasPrimaryLocation W43869574631 @default.
• W4386957463 hasRelatedWork W147290333 @default.
• W4386957463 hasRelatedWork W2024518993 @default.
• W4386957463 hasRelatedWork W2082805292 @default.
• W4386957463 hasRelatedWork W2426623066 @default.
• W4386957463 hasRelatedWork W2514884906 @default.
• W4386957463 hasRelatedWork W2922238153 @default.
• W4386957463 hasRelatedWork W3032164477 @default.
• W4386957463 hasRelatedWork W3032748235 @default.
• W4386957463 hasRelatedWork W3128343078 @default.
• W4386957463 hasRelatedWork W4385460702 @default.
• W4386957463 isParatext "false" @default.
• W4386957463 isRetracted "false" @default.
• W4386957463 workType "article" @default.